Xiaonan Liu
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 5
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Molecular Biology top 10%
- RNA modifications and cancer 4
- Metabolism, Diabetes, and Cancer 3
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms 8
-
- Renal Transplantation Outcomes and Treatments 3
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaonan Liu
71 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 753
- Molecular Biology 1.1k
- Rheumatology 227
- Complementary and Manual Therapy 30
- Orthopedics and Sports Medicine 97
Countries citing papers authored by Xiaonan Liu
This map shows the geographic impact of Xiaonan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Liu more than expected).
Fields of papers citing papers by Xiaonan Liu
This network shows the impact of papers produced by Xiaonan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Liu. The network helps show where Xiaonan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaonan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2023 | 38 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 67 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 79 | |
| 10 | 2021 | 44 | |
| 11 | 2021 | 11 | |
| 12 | Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis developmentbreakdown → | 2020 | 144 |
| 13 | 2020 | 14 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 48 | |
| 16 | 2019 | 12 | |
| 17 | 2018 | 48 | |
| 18 | 2018 | 31 | |
| 19 | 2011 | 311 | |
| 20 | 2009 | 30 |
About Xiaonan Liu
Xiaonan Liu is a scholar working on Transplantation, Cancer Research and Complementary and Manual Therapy, having authored 73 papers that have together received 2.3k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (8 papers), Cancer, Lipids, and Metabolism (5 papers), RNA modifications and cancer (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Metabolism, Diabetes, and Cancer (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (753 citations), Molecular Biology (1.1k citations) and Rheumatology (227 citations). Xiaonan Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qiming J. Wang, Fanning Zeng, Feihong Deng, Mei Wan, Xu Cao, Kaichun Wu, Yongquan Shi, Xiaohua Li, Xianli He and Weiping Su. Their work appears in journals such as Nature Communications, PLoS ONE and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.